Prolerity Clinical Research Appoints Erica Prowisor as Executive Vice President of Transformation and Patient Engagement and Michael Smith as Chief Commercial Officer
Position
Chief Commercial Officer
Company
Prolerity Clinical Research
United StatesBiotechnologyHealth CareDescription
Prolerity Clinical Research announced the appointments of Erica Prowisor as Executive Vice President of Transformation and Patient Engagement, and Michael Smith as Chief Commercial Officer. Both executives are expected to fuel the company's growth and extend its reach to patients benefiting from the research conducted on behalf of pharma and biotech sponsors.
Quick answer
Prolerity Clinical Research Appoints Erica Prowisor as Executive Vice President of Transformation and Patient Engagement and Michael Smith as Chief Commercial Officer (December 4, 2024). Prolerity Clinical Research is based in United States.
- Who is the new Chief Commercial Officer at Prolerity Clinical Research?
- Prolerity Clinical Research named Michael Smith Chief Commercial Officer, announced December 4, 2024.
- What did Prolerity Clinical Research announce on December 4, 2024?
- Prolerity Clinical Research announced the appointments of Erica Prowisor as Executive Vice President of Transformation and Patient Engagement, and Michael Smith as Chief Commercial Officer. Both executives are expected to fuel the company's growth and extend its reach to patients benefiting from the research conducted on behalf of pharma and biotech sponsors.
- What does Prolerity Clinical Research do?
- Prolerity Clinical Research strives to advance medicine while improving patients' quality of life through clinical research.
- Where is Prolerity Clinical Research based?
- Prolerity Clinical Research is based in United States.
- Which similar companies made leadership changes around the same time?
- ITF Therapeutics (December 4, 2024), Qorvis (December 4, 2024), Franklin Biolabs (December 4, 2024) and Avania (December 3, 2024) also announced leadership changes within 45 days of Prolerity Clinical Research.
Source: Fundz verified event record.
Other recent leadership changes in Biotechnology and Health Care
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- ITF Therapeutics Appoints Erica L. Monaco as Chief Operating Officer (December 4, 2024)
- Qorvis Welcomes Benoit Lioud as Managing Director of Geneva Hub (December 4, 2024)
- Franklin Biolabs Names Vatsala Naageshwaran as Chief Executive Officer (December 4, 2024)
- Avania Appoints Charlene Dark as Chief Operating Officer (December 3, 2024)
- AdaptHealth Appoints Russell Schuster as Chief Commercial Officer (December 3, 2024)
- Incendia Therapeutics Appoints Bradford Smith as Chief Financial Officer (December 3, 2024)
Who to call at Prolerity Clinical Research, and when
A new leader at Prolerity Clinical Research brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Prolerity Clinical Research raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Prolerity Clinical Research, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Prolerity Clinical Research. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Prolerity Clinical Research changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Prolerity Clinical Research changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.